MedTrace Logo

Comparison of Intravenous Omeprazole to Ranitidine on Recurrent Bleeding After Endoscopic Treatment of Bleeding Ulcer

NCT00247130 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2015-04-03

No results posted yet for this study

Summary

The present study will compare the hemostasis-maintaining effects of intravenous omeprazole and ranitidine in patients with upper gastrointestinal hemorrhage that have undergone endoscopic hemostasis, to establish which anti-secretory medication prior to the start of oral alimentation is effective in preventing re-hemorrhage after hemostasis.

Conditions

  • Peptic Ulcers

Interventions

DRUG

Omeprazole

DRUG

Ranitidine

Sponsors & Collaborators

  • Keio University

    lead OTHER

Principal Investigators

  • Toshifumi Hibi, M.D., Ph.D. · Division of Gastroenterology, Department of Internal Medicine, Keio University School of Medicine

  • Hidekazu Suzuki, M.D., Ph.D. · Upper GI Research Center, Keio University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Primary Completion
2007-07-31
Completion
2007-07-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00247130 on ClinicalTrials.gov